Also, a postmortem study of AD patients without prior antidiabetic treatment found that those receiving combined insulin plus another antidiabetic agent had significantly lower amyloid plaque density in the hippocampus, entorhinal cortex, amygdala, and frontal cortex—while neurofibrillary tangle burden remained unaffected [416]. This evidence concerns the gene INS and Alzheimer disease.